Special Issue "Natural Compounds as Potential Antibacterial Agents"
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (30 April 2019).
Dr. Leena Hanski
Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki,FI-00014 Helsinki, Finland
Website | E-Mail
Interests: pharmaceutical biology, antibacterial agents, antiviral agents, natural products, bioactivity screening, intracellular bacteria, bacterial persistence, anti-inflammatory activities
Natural product research has a long and productive history in the search for antibacterial agents, highlighted by the significant proportion of antibiotics in current clinical use originating from these sources. Besides the registered drugs, natural compounds serve as antibacterials in a variety of complementary medicine applications, and investigating the safety and efficacy of these products is of critical importance. Owing to the fading efficacy of the current day antibacterials as a result of resistant and persistent bacterial strains, the need for new approaches in identifying and using natural compounds as antibacterials is highly relevant. This Special Issue focuses on the potential of natural compounds to combat the challenges caused by the current and emerging conditions resulting from bacterial infections. The topics of the submitted manuscripts may include, but are not limited to:
- Identification of new bioactive antibacterials
- Elucidating the mechanisms of action of antibacterial natural compounds
- Natural compounds as adjuvants for conventional antibiotics
- Formulation and pharmacokinetics of natural compound antibacterials
- Targeting virulence factors
- Postgenomics approaches for natural compound antibacterial research
Dr. Leena Hanski
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Natural product, antibacterial agent, mechanism of action, antibiotic resistance, persistent infection, latent infection, virulence factor, normal microbiota